Cytodyn Inc (CYDY)

[Cynmark24]

"Gilead's HIV Business Is More Cash Cow Than Shining Star"

http://seekingalpha.com/article/4026255-gileads-hiv-business-cash-cow-shining-star

Long, but very interesting article, includes:

Meanwhile, ViiV Healthcare (GlaxoSmithKline), Janssen (Johnson & Johnson), Merck, and a variety of other companies such as CytoDyn (OTCQB:CYDY) are in the process of advancing HIV treatment in a variety of ways. First of all, more fixed dosed combinations (FDCs) will enter the market to compete with Gilead's existing STRs. Additionally, ViiV Healthcare and Janssen are currently in the process of working on a long-acting injectable treatment (cabotegravir + edurant) that would only require an injection once every eight weeks.